Rallybio Corp
RLYB
Get informed when a big investor buys or sells
+ FollowMarket Cap$88.2M
Close$
$6.64
60% downside
Current Fair Value
60% downsideOvervalued by 60% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $88.20 Million |
|---|---|
| Enterprise Value | $-3,379,422.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.59 |
| Beta | -0.85 |
| Outstanding Shares | 5,699,111 |
Return
| Return on Equity | 48.20% |
|---|---|
| Return on Assets | 46.45% |
| Return on Invested Capital | 28.49% |
Valuation & Multiples
| P/E Ratio | 2.1 |
|---|---|
| PEG | -0.38 |
| Price to Sales | - |
| Price to Book Ratio | 1.04 |
| Enterprise Value to Revenue | -5.23 |
| Enterprise Value to EBIT | -0.13 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | -0.38 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-1.28
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-1.44
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 71.35%▼ 10.68% |
|---|---|
| Total Invested | $65.06M▲ 55.45% |
| Investors Holding | 380% |
ESG Score
No data
About Rallybio Corp
2,021 employees